trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Despite the increase of serum CA 19-9, complete metabolic response and tumoral calcifications in PET/CT: Could it be a tumor stunning after chemotherapy?

G. Alçin ; E. Arslan ; N. Ergül ; T. Aksoy ; G. Tatar ; T.F. Çermik |

Dans Médecine nucléaire (vol. 46, n°4, Août 2022)

A 74-year-old male patient with a history of nausea, vomiting, and loss of appetite revealed thickening of the antrum and pylorus in gastroscopy and non-mucinous adenocarcinoma was diagnosed in the biopsy. The patient underwent 18F-FDG PET/CT fo[...]

Plus d'information... En ligne

Article

The value of 99mTc-MIBI scan in the detection of malignancy potential of hypermetabolic thyroid incidentalomas of 18F-FDG PET/CT

G. Tatar ; G. Alçın ; Ö. Erol Fenercioğlu ; E. Beyhan ; H.Y. Barut ; N. Ergül ; T.F. Çermik |

Dans Médecine nucléaire (vol. 46, n°3, Juin 2022)

Aim of the study Increasingly use of PET/CT leads to discovery of incidental findings. Hypermetabolic thyroid nodules are one of the unexpected lesions in PET/CT imaging with an increased risk of thyroid cancers. Our study aims to determine the [...]

Plus d'information... En ligne

Article

Thyroid metastasis of prostate cancer as a rare entity detected by 68Ga-PSMA PET/CT

R. Şahin ; B. Güzelbey ; E. Arslan ; N. Ergül ; T.F. Çermik |

Dans Médecine nucléaire (vol. 46, n°5-6, Novembre 2022)

Extremely rare cases of thyroid metastasis from prostate cancer (PC) have been reported in the literature. This patient demonstrated an unusual thyroid metastasis from PC detected by 68Ga-prostate-specific membrane antigen-11 (68Ga-PSMA) PET/CT [...]

Plus d'information... En ligne